NDC 0061-4305 - Resflor Gold

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0061-4305
Package NDCs from labels
0061-4305-01, 0061-4305-02, 0061-4305-03
Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2026-09-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Resflor GOLD ®Merck Sharp & Dohme Corp.2026-09-10PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0061-4305-01Resflor Gold100 mL in 1 VIAL, MULTI-DOSEINJECTION1005
0061-4305-01Resflor Gold1 in 1 CARTONINJECTION15
0061-4305-02Resflor Gold250 mL in 1 VIAL, MULTI-DOSEINJECTION2505
0061-4305-03Resflor Gold500 mL in 1 VIAL, MULTI-DOSEINJECTION5005

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0061-4305RESFLOR GOLD (FLORFENICOL AND FLUNIXIN MEGLUMINE) INJECTION [MERCK SHARP & DOHME CORP.]54 package rows20241121_e622cfd8-2749-4a6f-b347-988806432c88.zip

DailyMed Socrata Ingredients#

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.